Literature DB >> 27638684

A little cooperation helps murine cytomegalovirus (MCMV) go a long way: MCMV co-infection rescues a chemokine salivary gland defect.

Pranay Dogra1, Mindy Miller-Kittrell1, Elisabeth Pitt1, Joseph W Jackson1, Tom Masi1, Courtney Copeland1, Shuen Wu2, William E Miller2, Tim Sparer1.   

Abstract

Cytomegaloviruses (CMVs) produce chemokines (vCXCLs) that have both sequence and functional homology to host chemokines. Assessment of vCXCL-1's role in CMV infection is limited to in vitro and in silico analysis due to CMVs species specificity. In this study, we used the murine CMV (MCMV) mouse model to evaluate the function of vCXCL-1 in vivo. Recombinant MCMVs expressing chimpanzee CMV vCXCL-1 (vCXCL-1CCMV) or host chemokine, mCXCL1, underwent primary dissemination to the popliteal lymph node, spleen and lung similar to the parental MCMV. However, neither of the recombinants expressing chemokines was recovered from the salivary gland (SG) at any time post-infection although viral DNA was detected. This implies that the virus does not grow in the SG or the overexpressed chemokine induces an immune response that leads to suppressed growth. Pointing to immune suppression of virus replication, recombinant viruses were isolated from the SG following infection of immune-ablated mice [i.e. SCID (severe combined immunodeficiency), NSG (non-obese diabetic SCID gamma) or cyclophosphamide treated]. Depletion of neutrophils or NK cells does not rescue the recovery of chemokine-expressing recombinants in the SG. Surprisingly we found that co-infection of parental virus and chemokine-expressing virus leads to the recovery of the recombinants in the SG. We suggest that parental virus reduces the levels of chemokine expression leading to a decrease in inflammatory monocytes and subsequent SG growth. Therefore, aberrant expression of the chemokines induces cells of the innate and adaptive immune system that curtail the growth and dissemination of the recombinants in the SG.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27638684      PMCID: PMC5770846          DOI: 10.1099/jgv.0.000603

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  72 in total

1.  Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.

Authors:  R L Saltzman; M R Quirk; M C Jordan
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 2.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection.

Authors:  N Saederup; S A Aguirre; T E Sparer; D M Bouley; E S Mocarski
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination.

Authors:  Helen E Farrell; Nick Davis-Poynter; Kimberley Bruce; Clara Lawler; Lars Dolken; Michael Mach; Philip G Stevenson
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

5.  An analysis of retinal cotton-wool spots and cytomegalovirus retinitis in the acquired immunodeficiency syndrome.

Authors:  J S Pepose; M S Nestor; G N Holland; A J Cochran; R Y Foos
Journal:  Am J Ophthalmol       Date:  1983-01       Impact factor: 5.258

Review 6.  Cytomegalovirus infections during pregnancy.

Authors:  Giovanni Nigro; Stuart P Adler
Journal:  Curr Opin Obstet Gynecol       Date:  2011-04       Impact factor: 1.927

7.  Polymorphisms within human cytomegalovirus chemokine (UL146/UL147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children.

Authors:  Jinho Heo; Susie Petheram; Gail Demmler; Jody R Murph; Stuart P Adler; James Bale; Tim E Sparer
Journal:  Virology       Date:  2008-06-16       Impact factor: 3.616

Review 8.  Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation.

Authors:  Brian P McSharry; Selmir Avdic; Barry Slobedman
Journal:  Viruses       Date:  2012-10-25       Impact factor: 5.048

9.  Differential chemotactic receptor requirements for NK cell subset trafficking into bone marrow.

Authors:  Giovanni Bernardini; Giuseppe Sciumè; Angela Santoni
Journal:  Front Immunol       Date:  2013-01-30       Impact factor: 7.561

10.  Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV.

Authors:  Maria A Stacey; Morgan Marsden; Tu Anh Pham N; Simon Clare; Garry Dolton; Gabrielle Stack; Emma Jones; Paul Klenerman; Awen M Gallimore; Philip R Taylor; Robert J Snelgrove; Trevor D Lawley; Gordon Dougan; Chris A Benedict; Simon A Jones; Gavin W G Wilkinson; Ian R Humphreys
Journal:  Cell Host Microbe       Date:  2014-04-09       Impact factor: 21.023

View more
  4 in total

1.  Murine Cytomegalovirus Deubiquitinase Regulates Viral Chemokine Levels To Control Inflammation and Pathogenesis.

Authors:  Adam T Hilterbrand; Daniel R Boutz; Edward M Marcotte; Jason W Upton
Journal:  MBio       Date:  2017-01-17       Impact factor: 7.867

2.  The Human Cytomegalovirus Chemokine vCXCL-1 Modulates Normal Dissemination Kinetics of Murine Cytomegalovirus In Vivo.

Authors:  Joseph W Jackson; Trevor J Hancock; Ellen LaPrade; Pranay Dogra; Eric R Gann; Thomas J Masi; Ravichandran Panchanathan; William E Miller; Steven W Wilhelm; Tim E Sparer
Journal:  mBio       Date:  2019-06-25       Impact factor: 7.867

Review 3.  Where do we Stand after Decades of Studying Human Cytomegalovirus?

Authors:  Francesca Gugliesi; Alessandra Coscia; Gloria Griffante; Ganna Galitska; Selina Pasquero; Camilla Albano; Matteo Biolatti
Journal:  Microorganisms       Date:  2020-05-08

Review 4.  There Is Always Another Way! Cytomegalovirus' Multifaceted Dissemination Schemes.

Authors:  Joseph W Jackson; Tim Sparer
Journal:  Viruses       Date:  2018-07-20       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.